Agreement supports the first ‘Treat All’ programme for HIV in sub-Saharan Africa, where 70% of people with HIV live
GSK, Fondazione Telethon and Ospedale San Raffaele announce publication of pivotal safety and efficacy of gene therapy for children with ADA-SCID
GSK today announced the publication in BLOOD of the long-term safety and efficacy data from an analysis of 18 children with ADA-SCID
Salford Lung Study results show COPD patients treated with Relvar® Ellipta® achieve superior reduction in exacerbations compared with ‘usual care’
Pioneering GSK study provides important new data on the effectiveness of Relvar Ellipta (FF/VI) when used in everyday clinical practice.
GSK presents new data at the American Thoracic Society Conference from two pre-specified analyses from the Study to Understand Mortality and MorbidITy (SUMMIT) trial